The TUSK Practice Sales Q3 2026 Dental Market Report confirms that dental practice consolidation has reached approximately 35% nationwide, with 175-plus practice locations changing hands in the first half of 2026 alone. As of July 2026, practice valuations are expected to compress from today's 5x to 9x-plus EBITDA toward a more conservative 4x to 6x range in the years ahead, a shift that independent practice owners — including those in Ontario and the Greater Toronto Area — should factor into transition planning now.
The dental industry has entered a new phase of maturity. What was once a fragmented profession of solo and small-group practices is now a sector where more than one-third of all dental office locations are affiliated with dental service organizations (DSOs), private equity groups, or multi-location operators. The TUSK Practice Sales Q3 2026 report, released in July 2026, provides the most detailed snapshot yet of how this consolidation wave is reshaping practice economics, buyer behaviour, and the strategic calculus for dentists considering a sale or transition.
For Canadian dental professionals — particularly those in Toronto, Mississauga, Vaughan, Markham, Brampton, and across the GTA — these trends are not abstract. Cross-border private equity activity, the Dentalcorp take-private by GTCR, and the growing presence of US-based DSOs in Canadian markets mean that the valuation dynamics described in the TUSK report have direct parallels north of the border.
175-Plus Practice Transactions in the First Half of 2026
According to TUSK Practice Sales, at least 175 reported dental practice locations were sold to DSOs, private equity groups, and other acquirers during the first six months of 2026. This transaction volume remained resilient relative to other healthcare verticals, suggesting that dental practices continue to be viewed as attractive acquisition targets even as broader economic uncertainty persists.
TUSK's client data reveals that practice owners who went to market in 2026 received an average of five or more competitive offers from a buyer universe of more than 135 DSOs and private equity groups. Perhaps more notably, final transaction values averaged 50% above initial offers — a clear signal that competitive bidding dynamics remain strong for well-positioned practices.
Pro Tip: If you are considering a practice sale within the next three to five years, begin tracking your normalized EBITDA now. TUSK's data consistently shows that practices with clean financial documentation, stable associate relationships, diversified revenue streams, and low owner-dependency achieve the highest valuations in competitive processes.
Industry Consolidation Reaches 35%
The American Dental Association (ADA) data cited in the TUSK report places the dental industry at roughly 35% consolidated — meaning that approximately one-third of all dental practice locations are now owned or managed by DSOs, corporate groups, or private equity-backed platforms. This is a significant milestone for a profession that was less than 10% consolidated just two decades ago.
For context, TUSK notes that dentistry is following the consolidation path of more mature healthcare verticals such as dermatology, ophthalmology, and veterinary medicine, where consolidation rates have climbed to 50% or higher before stabilizing. If dentistry follows this trajectory, the current wave of acquisitions is closer to its midpoint than its endpoint.
Valuation Compression: From 5x-9x to 4x-6x EBITDA
The most consequential finding in the TUSK Q3 report is the explicit expectation that dental practice valuations will compress over time. Today, DSOs and private equity groups are paying between 5x and 9x-plus EBITDA for dental practices, with the range widening depending on practice size, specialty mix, geographic desirability, and growth trajectory. TUSK projects that these multiples will gradually settle toward 4x to 6x EBITDA as the industry matures and consolidation reaches its later stages.
This projection is not speculative. It follows the established pattern in other consolidated healthcare sectors, where early-phase acquisition premiums give way to more disciplined pricing as the buyer universe becomes more experienced, debt markets tighten, and integration track records are scrutinized more carefully.
For practice owners, the implication is clear: the current valuation window, while still strong, is unlikely to persist indefinitely. Dentists who are within five to ten years of a planned exit should be actively benchmarking their practice metrics against buyer expectations rather than assuming that today's multiples will be available at the time of their eventual transition.
Deal Structure: 60% to 85% Cash at Close
TUSK reports that DSO offers in 2026 continue to be structured with 60% to 85% or more of the total consideration paid as cash at closing. The remainder typically takes the form of equity rollovers, earnouts tied to post-acquisition performance, or deferred payments structured over one to three years.
The persistence of high cash-at-close ratios suggests that DSO buyers remain confident in dental practice economics and are willing to absorb more upfront risk to win competitive deals. For sellers, this means that the quality of offer evaluation matters as much as the headline number — a $2 million offer with 85% cash at close and no earnout conditions may be more valuable in practice than a $2.5 million offer with 60% cash and aggressive performance targets.
Pro Tip: When evaluating DSO or private equity offers, focus on the net present value of the total package, not just the EBITDA multiple. Factor in the cash-at-close percentage, earnout probability, equity rollover risk, and any post-acquisition employment commitments before comparing offers on a like-for-like basis.
Notable Industry Developments in H1 2026
The TUSK report highlights several significant developments in the first half of 2026 that signal both the maturation and the ongoing dynamism of the dental M&A market:
- Park Dental Partners began trading on Nasdaq in Q1 2026, becoming one of the first dental platforms to access public equity markets since Dentalcorp's listing and subsequent take-private transaction.
- Dental Care Alliance completed a debt restructuring in Q2 2026, underscoring the financial pressures that some larger DSO platforms face as they manage the integration costs and operational complexity of rapid multi-location expansion.
- The buyer universe expanded to 135-plus active DSOs and PE groups, indicating that new entrants continue to see dental as an attractive investment thesis despite the sector's advancing consolidation.
What Canadian Practice Owners Should Take Away
While the TUSK report focuses primarily on the US market, its findings resonate directly with Canadian dental professionals. The GTA dental market has experienced its own consolidation wave, with practices in Toronto, Mississauga, Brampton, and Markham trading at 130% to 150% of annual gross revenue, or 5.0x to 7.0x normalized EBITDA for solo general practices, according to recent Canadian transaction data.
Cross-border private equity activity — including the completed Dentalcorp take-private by GTCR for C$2.2 billion and 123Dentist's ongoing acquisition of MCA Dental Group — means that the valuation compression TUSK describes could reach Canadian markets within the next few years as well.
For independent practice owners in Ontario and across Canada, the strategic takeaway is threefold:
- Benchmark now. Understand your practice's normalized EBITDA, overhead ratio, and revenue per operatory relative to buyer expectations. Clean financials and low owner-dependency are the two most impactful levers you can control.
- Timing matters more than it used to. The current valuation environment is historically strong but expected to moderate. If a transition is within your five-to-ten-year horizon, beginning the preparation process sooner rather than later is a hedge against future compression.
- Not all offers are equal. With 135-plus buyers actively competing, the range of offer structures is wide. Independent representation — whether through a broker, advisor, or transition consultant — can materially improve the outcome of a competitive sale process.
The Bigger Picture: What 35% Consolidation Means for Everyday Practice
Beyond the transaction data, the TUSK report paints a picture of an industry at an inflection point. At 35% consolidation, the dental sector has crossed the threshold where DSO-affiliated practices are no longer outliers — they represent a structural segment of the market that influences everything from fee schedules and supply chain pricing to hiring competition and patient expectations.
For independent practices that are not considering a sale, the implications are still significant. DSO-affiliated offices often have advantages in purchasing power, technology investment, and marketing spend. Independent practices can compete effectively by focusing on clinical excellence, patient relationships, community reputation, and operational efficiency — areas where smaller, owner-operated offices can often outperform corporate models.
The dental profession is not disappearing — it is restructuring. Understanding the pace, direction, and economic forces driving that restructuring is essential for every practice owner, whether their goal is to sell, compete, or simply plan for the next decade of independent practice.
Frequently Asked Questions
Q: What does the TUSK Q3 2026 dental market report say about practice valuations?
The TUSK Q3 2026 report indicates that dental practice valuations currently range from 5x to 9x-plus EBITDA but are expected to compress toward 4x to 6x EBITDA as the industry matures. At least 175 practice locations were sold in the first half of 2026, with TUSK clients receiving an average of five or more competitive offers and final transaction values averaging 50% above initial offers.
Q: How consolidated is the dental industry in 2026?
According to ADA data cited in the TUSK report, the dental industry is approximately 35% consolidated as of mid-2026, meaning roughly one-third of all dental practice locations are now affiliated with DSOs, private equity groups, or multi-location platforms. This is up from less than 10% approximately two decades ago, and the sector is expected to follow other healthcare verticals toward 50% or higher consolidation.
Q: Should Canadian dentists be concerned about US dental consolidation trends?
Yes. Cross-border private equity activity is already reshaping the Canadian dental market. The Dentalcorp take-private by GTCR for C$2.2 billion and 123Dentist's expansion through acquisitions demonstrate that the same consolidation forces are active in Canada. GTA practices currently trade at 5.0x to 7.0x normalized EBITDA, but the valuation compression TUSK describes could arrive in Canadian markets within the next several years.
EBIKO Dental will continue monitoring dental industry consolidation trends and their impact on independent Canadian practices. For dental supplies and equipment to support your practice operations, visit ebiko.ca.